Kieng B. Vang

1.6k total citations
28 papers, 1.3k citations indexed

About

Kieng B. Vang is a scholar working on Immunology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Kieng B. Vang has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Biomedical Engineering. Recurrent topics in Kieng B. Vang's work include Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (6 papers). Kieng B. Vang is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (6 papers). Kieng B. Vang collaborates with scholars based in United States, Romania and Netherlands. Kieng B. Vang's co-authors include Michael A. Farrar, Jianying Yang, Matthew A. Burchill, Amanda L. Vegoe, Shawn A. Mahmud, Chyi‐Song Hsieh, Marc K. Jenkins, Hunghao Chu, Chan‐Wang Jerry Lio and James Moon and has published in prestigious journals such as Immunity, The Journal of Immunology and PLoS ONE.

In The Last Decade

Kieng B. Vang

28 papers receiving 1.2k citations

Peers

Kieng B. Vang

IMMUN

ONCOL

GENET

Ricardo A. Chaurio Germany

Jeremiah L. Oyer United States

Stéphanie Cornen France

Roberta Carosio Italy

Elisabetta Botti Italy

Shaojun Xing China

Chuanhui Han United States

Alexandra Flemming United States

Dandan Wan China

Karthik Tiruthani United States

Ricardo A. Chaurio Germany

Kieng B. Vang

618 ×0.7

IMMUN

436 ×1.8

168 ×0.8

ONCOL

118 ×0.8

41 ×0.5

GENET

Citations per year, relative to Kieng B. Vang Kieng B. Vang (= 1×) peers Ricardo A. Chaurio

Countries citing papers authored by Kieng B. Vang

Since Specialization

Citations

This map shows the geographic impact of Kieng B. Vang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kieng B. Vang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kieng B. Vang more than expected).

Fields of papers citing papers by Kieng B. Vang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kieng B. Vang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kieng B. Vang. The network helps show where Kieng B. Vang may publish in the future.

Co-authorship network of co-authors of Kieng B. Vang

This figure shows the co-authorship network connecting the top 25 collaborators of Kieng B. Vang. A scholar is included among the top collaborators of Kieng B. Vang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kieng B. Vang. Kieng B. Vang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jenkins, Samir V., Shruti Shah, Azemat Jamshidi‐Parsian, et al.. (2023). Abstract 1088: Acquired radiation resistance induces thiol-dependent cisplatin cross-resistance. Cancer Research. 83(7_Supplement). 1088–1088. 1 indexed citations

Vue, Zer, Moua Yang, Shany E. Yang, et al.. (2023). Stories from Hmong in STEMM. Trends in Genetics. 39(8). 587–592. 1 indexed citations

Jenkins, Samir V., Mahmood Alimohammadi, Robert J. Griffin, et al.. (2021). Dysbiotic stress increases the sensitivity of the tumor vasculature to radiotherapy and c-Met inhibitors. Angiogenesis. 24(3). 597–611. 3 indexed citations

Nima, Zeid A., et al.. (2021). Gold nanorods enhance different immune cells and allow for efficient targeting of CD4+ Foxp3+ Tregulatory cells. PLoS ONE. 16(8). e0241882–e0241882. 3 indexed citations

Bourdo, Shawn E., et al.. (2020). Graphene-based 2D constructs for enhanced fibroblast support. PLoS ONE. 15(5). e0232670–e0232670. 16 indexed citations

Jenkins, Samir V., Michael S. Robeson, Robert J. Griffin, et al.. (2019). Gastrointestinal Tract Dysbiosis Enhances Distal Tumor Progression through Suppression of Leukocyte Trafficking. Cancer Research. 79(23). 5999–6009. 27 indexed citations

Nima, Zeid A., Kieng B. Vang, Dmitry A. Nedosekin, et al.. (2019). Quantification of cellular associated graphene and induced surface receptor responses. Nanoscale. 11(3). 932–944. 9 indexed citations

Owen, David L., Shawn A. Mahmud, Kieng B. Vang, et al.. (2018). Identification of Cellular Sources of IL-2 Needed for Regulatory T Cell Development and Homeostasis. The Journal of Immunology. 200(12). 3926–3933. 65 indexed citations

Jenkins, Samir V., Kieng B. Vang, Allen Gies, et al.. (2018). Sample storage conditions induce post-collection biases in microbiome profiles. BMC Microbiology. 18(1). 227–227. 26 indexed citations

10.

Nima, Zeid A., Kieng B. Vang, Alexandru R. Biriş, et al.. (2017). Raman spectroscopy using plasmonic and carbon-based nanoparticles for cancer detection, diagnosis, and treatment guidance.Part 1: Diagnosis. Drug Metabolism Reviews. 49(2). 212–252. 24 indexed citations

11.

Nima, Zeid A., Kieng B. Vang, Robert J. Griffin, et al.. (2017). Raman spectroscopy using plasmonic and carbon-based nanoparticles for cancer detection, diagnosis, and treatment guidance. Part 2: Treatment. Drug Metabolism Reviews. 49(2). 253–283. 14 indexed citations

12.

Vang, Kieng B., Dmitry A. Nedosekin, Zeid A. Nima, et al.. (2017). Modifying Dendritic Cell Activation with Plasmonic Nano Vectors. Scientific Reports. 7(1). 5513–5513. 25 indexed citations

13.

Jenkins, Samir V., Zeid A. Nima, Kieng B. Vang, et al.. (2017). Triple-negative breast cancer targeting and killing by EpCAM-directed, plasmonically active nanodrug systems. npj Precision Oncology. 1(1). 27–27. 45 indexed citations

14.

Koonce, Nathan A., Joseph Levy, Matthew E. Hardee, et al.. (2015). Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular Hypoxia. PLoS ONE. 10(8). e0135607–e0135607. 14 indexed citations

15.

Dings, Ruud P.M., Kieng B. Vang, Karolien Castermans, et al.. (2011). Enhancement of T-cell–Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against Cancer. Clinical Cancer Research. 17(10). 3134–3145. 59 indexed citations

16.

Heltemes-Harris, Lynn, Mark Willette, Kieng B. Vang, & Michael A. Farrar. (2011). The role of STAT5 in the development, function, and transformation of B and T lymphocytes. Annals of the New York Academy of Sciences. 1217(1). 18–31. 30 indexed citations

17.

Vang, Kieng B., Jianying Yang, Antonio J. Pagán, et al.. (2010). Cutting Edge: CD28 and c-Rel–Dependent Pathways Initiate Regulatory T Cell Development. The Journal of Immunology. 184(8). 4074–4077. 94 indexed citations

18.

Vang, Kieng B., Jianying Yang, Shawn A. Mahmud, et al.. (2008). IL-2, -7, and -15, but Not Thymic Stromal Lymphopoeitin, Redundantly Govern CD4+Foxp3+ Regulatory T Cell Development. The Journal of Immunology. 181(5). 3285–3290. 206 indexed citations

19.

Burchill, Matthew A., Jianying Yang, Kieng B. Vang, et al.. (2008). Linked T Cell Receptor and Cytokine Signaling Govern the Development of the Regulatory T Cell Repertoire. Immunity. 28(1). 112–121. 321 indexed citations

20.

Burchill, Matthew A., Jianying Yang, Kieng B. Vang, & Michael A. Farrar. (2007). Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunology Letters. 114(1). 1–8. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact